Literature DB >> 8618331

Minimal hydronephrosis in the fetus: clinical significance and implications for management.

L Morin1, M Cendron, T M Crombleholme, S H Garmel, G T Klauber, M E D'Alton.   

Abstract

PURPOSE: We further define the natural history and management of minimal fetal hydronephrosis.
MATERIALS AND METHODS: Experience with minimal fetal hydronephrosis (renal pelvic diameter 4 to 10 mm. before 20 weeks of gestation and 5 to 10 mm. from 20 to 24 weeks) was reviewed for 18 months at New England Medical Center.
RESULTS: The incidence of minimal fetal hydronephrosis was 2.2% in the 5,900 fetuses screened by ultrasound. In 63% of cases prenatal ultrasound was done more than once, and revealed that dilatation of the urinary tract was stable during gestation in 31 (25%), and became normal in 35 (29%) and worse in 11 (9%). A total of 63 patients (103 renal units) followed for up to 1 year underwent postnatal sonography. Those with abnormalities were screened with a voiding cystourethrogram and renal scan, including 40 with normal postnatal ultrasound and no changes on subsequent evaluation. Of the 23 patients with abnormal findings 4 had functionally significant ureteropelvic junction obstruction and 1 had severe vesicoureteral reflux. A retrospective analysis of the sonograms of patients with minimal fetal hydronephrosis and persistence or progression of hydronephrosis revealed calicectasis, progression of minimal fetal hydronephrosis in utero and/or abnormal renal echogenicity in each fetus.
CONCLUSIONS: Our study shows that in a small but significant number of fetuses minimal fetal hydronephrosis will progress, whereas in most it will resolve.

Entities:  

Mesh:

Year:  1996        PMID: 8618331     DOI: 10.1016/s0022-5347(01)66102-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  Postnatal management of hydronephrosis diagnosed in utero.

Authors:  J Radhakrishnan; G Lievano
Journal:  Indian J Pediatr       Date:  1997 May-Jun       Impact factor: 1.967

Review 2.  Management of fetal hydronephrosis.

Authors:  Jenny Yiee; Duncan Wilcox
Journal:  Pediatr Nephrol       Date:  2007-08-02       Impact factor: 3.714

Review 3.  Mild fetal renal pelvis dilatation: much ado about nothing?

Authors:  Daljit K Hothi; Angie S Wade; Ruth Gilbert; Paul J D Winyard
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 8.237

Review 4.  Outcome of isolated antenatal hydronephrosis: a systematic review and meta-analysis.

Authors:  Gagan Sidhu; Joseph Beyene; Norman D Rosenblum
Journal:  Pediatr Nephrol       Date:  2005-12-17       Impact factor: 3.714

Review 5.  Intrauterine surgery--choices and limitations.

Authors:  Anke Diemert; Werner Diehl; Peter Glosemeyer; Jan Deprest; Kurt Hecher
Journal:  Dtsch Arztebl Int       Date:  2012-09-21       Impact factor: 5.594

Review 6.  Prenatal hydronephrosis: postnatal evaluation and management.

Authors:  Vijaya Vemulakonda; Jenny Yiee; Duncan T Wilcox
Journal:  Curr Urol Rep       Date:  2014-08       Impact factor: 3.092

7.  MR urography in children. Part 1: how we do the F0 technique.

Authors:  Pierre-Hugues Vivier; Michael Dolores; Melissa Taylor; Frederic Elbaz; Agnes Liard; Jean-Nicolas Dacher
Journal:  Pediatr Radiol       Date:  2010-02-25

8.  Postnatal management of infants with antenatally detected hydronephrosis.

Authors:  Nejat Aksu; Onder Yavaşcan; Murat Kangin; Orhan D Kara; Yahya Aydin; Hakan Erdoğan; Tuba Cerçi Tuncel; Ergün Cetinkaya; Erkan Ozbay; Tahir G Sandikçioğlu
Journal:  Pediatr Nephrol       Date:  2005-07-16       Impact factor: 3.714

9.  Postnatal outcome of fetal hydronephrosis: implications for prenatal counselling.

Authors:  Ramesh Babu; Venkata Sai
Journal:  Indian J Urol       Date:  2010 Jan-Mar

10.  Pyeloplasty in children: perioperative results and long-term outcomes of robotic-assisted laparoscopic surgery compared to open surgery.

Authors:  Martin Salö; Tania Sjöberg Altemani; Magnus Anderberg
Journal:  Pediatr Surg Int       Date:  2016-02-01       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.